Growth Metrics

Codexis (CDXS) Net Income Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 32.79%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 60.43%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -46.86%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.80%
7 Evaxion A 64.16 Bn 64.14 Bn - 19.97%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 47.10%
10 Codexis 251.43 Mn 186.29 Mn 13.18 Mn 27.26%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 27.26%
Dec 31, 2025 40.30%
Sep 30, 2025 -25.21%
Jun 30, 2025 -71.31%
Mar 31, 2025 -35.28%
Dec 31, 2024 -0.60%
Sep 30, 2024 -123.72%
Jun 30, 2024 -74.74%
Mar 31, 2024 -8.26%
Dec 31, 2023 -22.42%
Sep 30, 2023 -78.93%
Jun 30, 2023 -22.01%
Mar 31, 2023 -43.51%
Dec 31, 2022 -170.76%
Sep 30, 2022 -214.58%
Jun 30, 2022 25.97%
Mar 31, 2022 -17.61%
Dec 31, 2021 -180.65%
Sep 30, 2021 46.26%
Jun 30, 2021 -4.52%
Mar 31, 2021 -24.54%
Dec 31, 2020 -82.13%
Sep 30, 2020 15.85%
Jun 30, 2020 -0.34%
Mar 31, 2020 -0.85%
Dec 31, 2019 50.58%
Sep 30, 2019 -37.97%
Jun 30, 2019 -69.92%
Mar 31, 2019 9.69%
Dec 31, 2018 39.22%
Sep 30, 2018 -33.30%
Jun 30, 2018 11.34%
Mar 31, 2018 5.50%
Dec 31, 2017 41.14%
Sep 30, 2017 -30.87%
Jun 30, 2017 9.52%
Mar 31, 2017 -5.38%
Dec 31, 2016 18.77%
Sep 30, 2016 29.17%
Jun 30, 2016 29.62%
Mar 31, 2016 10.18%
Dec 31, 2015 49.07%
Sep 30, 2015 63.07%
Jun 30, 2015 0.97%
Mar 31, 2015 9.44%
Dec 31, 2014 27.35%
Sep 30, 2014 -18.49%
Jun 30, 2014 -18.93%
Mar 31, 2014 -22.46%
Dec 31, 2013 -170.82%
Sep 30, 2013 -50.22%
Jun 30, 2013 -47.27%